Home LiteratureArticle Details
PMID: 3120186 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S. Research Support, U.S. Gov't, P.H.S.

Trypanosome mRNAs have unusual "cap 4" structures acquired by addition of a spliced leader.

Perry KL, Watkins KP, Agabian N

Abstract

A single capped oligonucleotide is released from Trypanosoma brucei poly(A)+ RNA upon digestion with RNase T2. This observation supports the hypothesis that all T. brucei mRNAs share a common leader sequence. Digestion of the T2-resistant species with nucleotide pyrophosphatase shows that the capping nucleotide is 7-methylguanosine 5'-monophosphate (pm7G). Additional characterization of the T2-resistant fragment indicates that modifications are present on the first four transcribed nucleotides; the 5' termini of T. brucei mRNAs can, therefore, be described as "cap 4" structures. Identical 5'-cap structures are found on the T. brucei spliced leader (SL) RNA; an observation compatible with the hypothesis that the small SL RNA acts as a donor of the SL for the mRNA. However, we find that within a population of purified SL RNAs are species that are capped but incompletely modified. The presence of these unmodified and partially modified species allowed us to analyze the 5' sequence of the SL RNA transcript. The results indicate that transcription begins four nucleotides upstream of the reported 5' end. Therefore, the T. brucei SL transcript is actually 39 rather than 35 nucleotides long. We have also analyzed the capped oligonucleotide of a distantly related Trypanosomatid, Leptomonas collosoma and find it to be identical to that of T. brucei. The potential significance of these results is discussed in light of observations of trypanosome gene expression.

MeSH Terms
Animals Base Sequence Methylation RNA Caps RNA Splicing RNA, Messenger/genetics Trypanosoma brucei brucei/genetics Trypanosomatina/genetics
Chemicals
RNA Caps RNA, Messenger
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Perry K L
School of Public Health, University of California, Berkeley 94720.
Watkins K P
Agabian N
References (21)
21 references, click to expand
  1. Conservation of the primary structure at the 3' end of 18S rRNA from eucaryotic cells.
    Cell. 1978 Mar;13(3):551-63 PMID: 77738
  2. Evidence for trans splicing in trypanosomes.
    Cell. 1986 Nov 21;47(4):527-35 PMID: 3022935
  3. Reverse transcriptase pauses at N2-methylguanine during in vitro transcription of Escherichia coli 16S ribosomal RNA.
    Proc Natl Acad Sci U S A. 1979 Aug;76(8):3751-4 PMID: 91169
  4. 5'-terminal cap structure in eucaryotic messenger ribonucleic acids.
    Microbiol Rev. 1980 Jun;44(2):175-205 PMID: 6247631
  5. Trypanosoma brucei: biochemical and morphological changes during in vitro transformation of bloodstream- to procyclic-trypomastigotes.
    Exp Parasitol. 1981 Jun;51(3):408-17 PMID: 6785103
  6. Tandem repetition of the 5' mini-exon of variant surface glycoprotein genes: a multiple promoter for VSG gene transcription?
    Cell. 1983 Oct;34(3):891-900 PMID: 6313212
  7. Sequences homologous to the variant antigen mRNA spliced leader are located in tandem repeats and variable orphons in trypanosoma brucei.
    Cell. 1983 Oct;34(3):901-9 PMID: 6313213
  8. Comparison of the genes coding for the common 5' terminal sequence of messenger RNAs in three trypanosome species.
    Nucleic Acids Res. 1984 Jun 11;12(11):4431-43 PMID: 6204273
  9. Apparent discontinuous transcription of Trypanosoma brucei variant surface antigen genes.
    Nature. 1984 Sep 27-Oct 3;311(5984):350-5 PMID: 6090933
  10. Identification of a small RNA containing the trypanosome spliced leader: a donor of shared 5' sequences of trypanosomatid mRNAs?
    Cell. 1984 Oct;38(3):721-9 PMID: 6091897
  11. Recognition of cap structure in splicing in vitro of mRNA precursors.
    Cell. 1984 Oct;38(3):731-6 PMID: 6567484
  12. Discontinuous synthesis of mRNA in trypanosomes.
    EMBO J. 1984 Oct;3(10):2387-92 PMID: 6094183
  13. The IsTaR 1 serodeme of Trypanosoma brucei: development of a new serodeme.
    J Parasitol. 1984 Oct;70(5):747-54 PMID: 6439844
  14. Secondary structure of the circular form of the Tetrahymena rRNA intervening sequence: a technique for RNA structure analysis using chemical probes and reverse transcriptase.
    Proc Natl Acad Sci U S A. 1985 Feb;82(3):648-52 PMID: 2579378
  15. Mature mRNAs of Trypanosoma brucei possess a 5' cap acquired by discontinuous RNA synthesis.
    Nucleic Acids Res. 1985 Jun 25;13(12):4253-66 PMID: 2409534
  16. Cap-dependent RNA splicing in a HeLa nuclear extract.
    Proc Natl Acad Sci U S A. 1985 Nov;82(22):7590-4 PMID: 3865180
  17. The spliced leader sequence of Trypanosoma brucei has a potential role as a cap donor structure.
    Mol Cell Biol. 1985 Sep;5(9):2487-90 PMID: 3837191
  18. Discontinuous transcription and antigenic variation in trypanosomes.
    Annu Rev Biochem. 1986;55:701-32 PMID: 2874767
  19. Cloning and characterization of a Leishmania gene encoding a RNA spliced leader sequence.
    Nucleic Acids Res. 1986 Sep 25;14(18):7341-60 PMID: 2429261
  20. Identification of a novel Y branch structure as an intermediate in trypanosome mRNA processing: evidence for trans splicing.
    Cell. 1986 Nov 21;47(4):517-25 PMID: 3779835
  21. Use of in vitro 32P labeling in the sequence analysis of nonradioactive tRNAs.
    Methods Enzymol. 1979;59:58-109 PMID: 220499
Article Info
Journal
Proceedings of the National Academy of Sciences of the United States of America
Abbr.
Proc Natl Acad Sci U S A
ISSN
0027-8424
Published
1987-12-00
Pages
8190-4
Language
English
Region
United States
NLM ID
7505876
PMCID
PMC299507
Subset
IM
Grants
NIAID NIH HHS · AI-21975 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]